Current
$24.1B
5-Year Average
$23.9B
All-Time High
$35.8B
All-Time Low
$240M
Market cap daily chart for West Pharmaceutical Services (WST)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for West Pharmaceutical Services (WST) from 2017 to 2026
Latest: +20.3%
Market Cap history table for West Pharmaceutical Services (WST) from 1985 to 2026
| 2026 | $24.1B | +20.3% | +$4.06B | ||
| 2025 | $20B | -17.1% | -$4.14B | ||
| 2024 | $24.1B | -9.0% | -$2.37B | ||
| 2023 | $26.5B | +48.6% | +$8.68B | ||
| 2022 | $17.8B | -50.1% | -$17.9B | ||
| 2021 | $35.8B | +66.6% | +$14.3B | ||
| 2020 | $21.5B | +89.5% | +$10.1B | ||
| 2019 | $11.3B | +53.4% | +$3.94B | ||
| 2018 | $7.39B | -1.2% | -$87.7M | ||
| 2017 | $7.48B | +17.6% | +$1.12B | ||
| 2016 | $6.36B | +43.2% | +$1.92B | ||
| 2015 | $4.44B | +14.7% | +$568M | ||
| 2014 | $3.88B | +10.6% | +$373M | ||
| 2013 | $3.5B | +78.2% | +$1.54B | ||
| 2012 | $1.97B | +40.0% | +$561M | ||
| 2011 | $1.4B | -7.1% | -$108M | ||
| 2010 | $1.51B | +6.3% | +$89.1M | ||
| 2009 | $1.42B | +4.3% | +$59.1M | ||
| 2008 | $1.36B | -7.2% | -$106M | ||
| 2007 | $1.47B | -14.6% | -$252M | ||
| 2006 | $1.72B | +111.6% | +$908M | ||
| 2005 | $814M | +5.5% | +$42.6M | ||
| 2004 | $771M | +56.5% | +$278M | ||
| 2003 | $493M | +39.8% | +$140M | ||
| 2002 | $353M | -7.6% | -$29.1M | ||
| 2001 | $382M | +7.8% | +$27.8M | ||
| 2000 | $354M | -23.9% | -$111M | ||
| 1999 | $465M | -21.0% | -$124M | ||
| 1998 | $589M | +19.4% | +$95.7M | ||
| 1997 | $493M | +6.4% | +$29.5M | ||
| 1996 | $464M | +19.1% | +$74.2M | ||
| 1995 | $389M | -11.9% | -$52.4M | ||
| 1994 | $442M | +12.7% | +$49.8M | ||
| 1993 | $392M | +10.4% | +$37.1M | ||
| 1992 | $355M | +23.2% | +$66.8M | ||
| 1991 | $288M | +47.8% | +$93.1M | ||
| 1990 | $195M | -37.1% | -$115M | ||
| 1989 | $310M | +27.0% | +$65.8M | ||
| 1988 | $244M | -9.7% | -$26.2M | ||
| 1987 | $270M | +19.3% | +$43.7M | ||
| 1986 | $226M | +11.0% | +$22.5M | ||
| 1985 | $204M | — | — |
- 2026$24.1B+20.3%
- 2025$20B-17.1%
- 2024$24.1B-9.0%
- 2023$26.5B+48.6%
- 2022$17.8B-50.1%
- 2021$35.8B+66.6%
- 2020$21.5B+89.5%
- 2019$11.3B+53.4%
- 2018$7.39B-1.2%
- 2017$7.48B+17.6%
- 2016$6.36B+43.2%
- 2015$4.44B+14.7%
- 2014$3.88B+10.6%
- 2013$3.5B+78.2%
- 2012$1.97B+40.0%
- 2011$1.4B-7.1%
- 2010$1.51B+6.3%
- 2009$1.42B+4.3%
- 2008$1.36B-7.2%
- 2007$1.47B-14.6%
- 2006$1.72B+111.6%
- 2005$814M+5.5%
- 2004$771M+56.5%
- 2003$493M+39.8%
- 2002$353M-7.6%
- 2001$382M+7.8%
- 2000$354M-23.9%
- 1999$465M-21.0%
- 1998$589M+19.4%
- 1997$493M+6.4%
- 1996$464M+19.1%
- 1995$389M-11.9%
- 1994$442M+12.7%
- 1993$392M+10.4%
- 1992$355M+23.2%
- 1991$288M+47.8%
- 1990$195M-37.1%
- 1989$310M+27.0%
- 1988$244M-9.7%
- 1987$270M+19.3%
- 1986$226M+11.0%
- 1985$204M—
Market Cap values are taken from West Pharmaceutical Services's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported market cap is $25.6B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for West Pharmaceutical Services (WST) came in at $24.1B – grew 20.3% year-over-year.
West Pharmaceutical Services market cap compound annual growth for the 2021–2026 (5 years) window is -7.6%, with a net decline across the window.
West Pharmaceutical Services market cap plunged from $35.8B in 2021 to $24.1B in 2026, a 32.8% drawdown.
The record annual market cap stands at $35.8B, reached in 2021; the historical low of $195M was recorded in 1990.
West Pharmaceutical Services Market Cap by Year
West Pharmaceutical Services Market Cap 2026: $24.1B
In 2026, West Pharmaceutical Services reported market cap of $24.1B, grew 20.3% from 2025.
West Pharmaceutical Services Market Cap 2025: $20B
West Pharmaceutical Services market cap in 2025 was $20B, declined 17.1% below 2024.
West Pharmaceutical Services Market Cap 2024: $24.1B
2024's market cap for West Pharmaceutical Services came in at $24.1B, declined 9.0% below 2023.
West Pharmaceutical Services Market Cap 2023: $26.5B
West Pharmaceutical Services posted market cap of $26.5B in 2023, surged 48.6% from 2022.
West Pharmaceutical Services Market Cap 2022: $17.8B
West Pharmaceutical Services market cap in 2022 was $17.8B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Market Cap
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on WST
Market Cap — 10 rounds, every one of them WST against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.34% TTM
- Dividend Profile0.32% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.